# A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults

> **NCT00360295** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 153 (actual)

## Conditions studied

- Pneumonia, Community-Acquired

## Interventions

- **DRUG:** Azithromycin SR

## Key facts

- **NCT ID:** NCT00360295
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2008-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00360295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00360295, "A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00360295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
